You are here: Industry Insights > Bristol-Myers Squibb

News List

Novartis, BMS in Opdivo Clinical Collaboration contractpharma
June 07, 2017
To investigate Mekinist with Opdivo and Opdivo + Yervoy in metastatic colorectal cancer
Bristol-Myers Squibb announces new collaboration to evaluate combination therapy in colorectal cance worldpharmanews
June 06, 2017
Bristol-Myers Squibb Company (NYSE:BMY) announced today it has entered into a clinical research collaboration with Novartis to investigate the safety, tolerability and efficacy of Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen in combination
Bristol-Myers Squibb Reports First Quarter Financial Results americanpharmaceuticalreview
April 28, 2017
Bristol-Myers Squibb posted first quarter 2017 revenues of $4.9 billion, an increase of 12% compared to the same period a year ago. Revenues increased 13% when adjusted for foreign exchange impact.
Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine’s Molecular Information Pl americanpharmaceuticalreview
March 31, 2017
Bristol-Myers Squibb Company and Foundation Medicine have announced a collaboration that leverages Foundation Medicine’s comprehensive genomic profiling and molecular information solutions to identify predictive biomarkers.
Bristol-Myers Squibb Names Executive Vice President and Chief Scientific Officer americanpharmaceuticalreview
March 09, 2017
Bristol-Myers Squibb Company has appointed Dr. Thomas J. Lynch, Jr., 56, executive vice president and chief scientific officer, effective March 16, 2017.
Bristol-Myers Squibb Expands Focus on Precision Medicine with Investment and Planned Collaboration w americanpharmaceuticalreview
March 03, 2017
Bristol-Myers Squibb Company has announced its equity investment and plans for a research collaboration with GRAIL Inc., a life sciences company whose mission is to detect cancer early when it potentially can be cured. By combining the power of high inten
Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia americanpharmaceuticalreview
February 28, 2017
Bristol-Myers Squibb Company has announced that Columbia University Medical Center and Peter MacCallum Cancer Centre (Peter Mac) have joined the International Immuno-Oncology Network (II-ON),
Carl Icahn purchases stake in Bristol-Myers Squibb: report firstwordpharma
February 22, 2017
According to people familiar with the matter, activist investor Carl Icahn has acquired a stake in Bristol-Myers Squibb, The Wall Street Journal reported Tuesday.
Bristol-Myers Squibb appoints three new independent directors worldpharmanews
February 22, 2017
Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has appointed Robert J. Bertolini, Matthew W. Emmens and Theodore R. Samuelsto its Board of Directors, effective immediately.
Bristol-Myers Squibb and pCPA sign agreement for OPDIVO treatment pharmaceutical-technology
February 14, 2017
Bristol-Myers Squibb Canada (BMS) and the pan-Canadian Pharmaceutical Alliance (pCPA) have signed an agreement for immuno-oncology treatment OPDIVO.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page